Recurrence: all 3,523 studies
Page 8 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cognition in AFRecruitingNCT05510167Not applicable
- Precision Medicine for Every Child With CancerRecruitingNCT05504772
- Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung CancerNot yet recruitingNCT05503888Phase 1/2
- SPEL as Introductive Treatment Following Immune-chemotherapy as Consolidated Therapy for R/R DLBCL With p53 and/or c-Myc ExpressionNot yet recruitingNCT05498636Phase 1/2
- Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell MalignanciesRecruitingNCT05487651Phase 1
- Letrozole in Preventing Recurrence of Endometrioma Following Laparoscopic Ovarian CystectomyRecruitingNCT05487092Not applicable
- BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT05474885Phase 1
- Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' DiseaseRecruitingNCT05461820Phase 4
- Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological MalignanciesRecruitingNCT05457595Not applicable
- Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular CarcinomaRecruitingNCT05444478Not applicable
- Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's LymphomaRecruitingNCT05436223Phase 2
- Pilot Trial for Treatment of Recurrent GlioblastomaEnrolling by invitationNCT05432518Early Phase 1
- Light and Ion Maintenance In Treatment for Depression (LIMIT-D): Feasibility StudyRecruitingNCT05423275Not applicable
- Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive SystemRecruitingNCT05420558
- Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in ChildrenNot yet recruitingNCT05406947
- Base Edited CAR7 T Cells to Treat T Cell Malignancies (TvT CAR7)RecruitingNCT05397184Phase 1
- BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHLRecruitingNCT05370430Phase 1
- Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage LeukemiaRecruitingNCT05366218Phase 1/2
- Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3TcRecruitingNCT05366179Phase 1
- Early Recurrences of Atrial Arrhythmias and Their Impact on Late Recurrence After Pulmonary Vein Isolation With Pulsed Field Ablation of Paroxysmal Atrial FibrillationRecruitingNCT05328882
- Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate CancerRecruitingNCT05328505Not applicable
- Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell LymphomaRecruitingNCT05313243Phase 2
- Prognosis of Low-grade Endometrial Stromal SarcomaRecruitingNCT05310318
- The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug ScreeningRecruitingNCT05304741
- Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)RecruitingNCT05302037Phase 1
- Venetoclax Basket Trial for High Risk Hematologic MalignanciesRecruitingNCT05292664Phase 1
- Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing TumorsRecruitingNCT05283330Phase 1
- Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant CandidatesRecruitingNCT05276037
- Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHNRecruitingNCT05260671Phase 2
- Feasibility Study of Lidocaine Infusion During Bowel Cancer Surgery for Cancer OutcomeRecruitingNCT05250791Not applicable
- Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell TransplantationRecruitingNCT05250362Phase 1/2
- Brentuximab Vedotin Plus DHAP in Relapsed or Refractory Hodgkin's LymphomaRecruitingNCT05243693Phase 2
- MRI/Ultrasound Fusion Guided Laser Ablation of Prostate CancerRecruitingNCT05241236
- A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)RecruitingNCT05241106Phase 2
- A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)RecruitingNCT05241093Phase 2
- Robotic Versus Hybrid Assisted Ventral Hernia RepairRecruitingNCT05233020Not applicable
- Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort StudyRecruitingNCT05229471
- Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System LymphomaRecruitingNCT05209620Phase 2
- Sutures Versus Polyglactin Mesh in Hiatal Hernia RepairRecruitingNCT05201508Not applicable
- Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant TumorsRecruitingNCT05189054
- A Study of Deferoxamine (DFO) in People With Leptomeningeal MetastasisRecruitingNCT05184816Phase 1
- Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence TestRecruitingNCT05176145Not applicable
- A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsRecruitingNCT05150691Phase 1/2
- Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid TumorsRecruitingNCT05150457Phase 1
- Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System LymphomaRecruitingNCT05135858Phase 1
- REMASTer: REcurrent Brain Metastases After SRS TrialRecruitingNCT05124912Not applicable
- CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell MalignanciesRecruitingNCT05105867Early Phase 1
- Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL PatientsRecruitingNCT05098613Phase 1
- Study of Pembrolizumab and M032 (NSC 733972)RecruitingNCT05084430Phase 1/2
- CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's LymphomaRecruitingNCT05054257Phase 1
- Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCCRecruitingNCT05047094Not applicable
- Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)RecruitingNCT05037279Phase 3
- Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)RecruitingNCT05010564Phase 1
- Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple MyelomaRecruitingNCT05007418Phase 1
- AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder CancerRecruitingNCT05002556
- Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior TherapiesNot yet recruitingNCT04994626Phase 2
- Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCLRecruitingNCT04994210Phase 2
- Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)RecruitingNCT04989621Phase 2
- A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)RecruitingNCT04988555Phase 1/2
- MRD Monitoring in Lung Cancer After ResectionRecruitingNCT04976296
- RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast CancerNot yet recruitingNCT04972448
- Abdominal or Transanal TME for Rectal Cancer TherapyRecruitingNCT04969107Not applicable
- Outcomes of Patients After Allo-HSCT With Decitabine and NACNot yet recruitingNCT04945096Phase 3
- The circTeloDIAG: Liquid Biopsy for Glioma TumorRecruitingNCT04931732
- A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After TreatmentRecruitingNCT04928677Phase 1
- Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian CancerRecruitingNCT04921527Phase 3
- Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.RecruitingNCT04915248Phase 2
- Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AMLRecruitingNCT04913922Phase 2
- Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesRecruitingNCT04907643Not applicable
- Robotic Radical Cystectomy OutcomesRecruitingNCT04900558
- Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent TumorsNot yet recruitingNCT04889742Phase 2
- Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell LymphomaRecruitingNCT04887025Phase 1
- Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic LeukemiaRecruitingNCT04825496Phase 1
- Plasma Biomarker for Aflibercept in Advanced Colorectal CancerRecruitingNCT04810585Phase 4
- Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS PatientsRecruitingNCT04809181Phase 2
- Phase Ib Clinical Study of KeynatinibRecruitingNCT04807881Phase 1
- Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal CarcinomaRecruitingNCT04778956Phase 3
- Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsRecruitingNCT04777994Phase 1
- Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.RecruitingNCT04771572Phase 1
- A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva CancerRecruitingNCT04761146Not applicable
- Most Preventable Surgical Option to Reduce Primary Spontaneous Pneumothorax Patients' Postoperative Recurrence: A Prospective Cohort StudyRecruitingNCT04758143
- Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor RecurrenceRecruitingNCT04741737Not applicable
- Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)RecruitingNCT04740346Not applicable
- Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast CancerRecruitingNCT04739670Phase 2
- Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT04716452Phase 1
- Southeast Asia Dose Optimization of TafenoquineRecruitingNCT04704999Phase 4
- The Therapy of Large EndometriomaRecruitingNCT04704115
- Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic LeukemiaRecruitingNCT04684147Phase 2
- Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid CarcinomaNot yet recruitingNCT04683575Phase 4
- Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer SurgeryRecruitingNCT04665635Not applicable
- European Blood Pressure Intensive Control After StrokeRecruitingNCT04647292Phase 2
- Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)RecruitingNCT04636775
- Genomic Profiles Analysis in Children, Adolescents and Young Adult With SarcomasRecruitingNCT04621201
- CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological MalignanciesRecruitingNCT04603872Early Phase 1
- A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or UbamatamabRecruitingNCT04590326Phase 1/2
- Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AMLRecruitingNCT04588922Phase 1/2
- UCD19 CarT in Treatment of Pediatric B-ALL and B-NHLRecruitingNCT04544592Phase 1/2
- Study of Pembrolizumab With Bendamustine in Hodgkin LymphomaRecruitingNCT04510636Phase 2
- HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular CarcinomaRecruitingNCT04499833Not applicable
- Prospective Observation of Failure Patterns in NSCLC Treated With ICIsNot yet recruitingNCT04492969